Using propensity score matching in a US nationally representative sample, authors found the effect of nonadherence to diabetes guidelines on health care expenditures of patients with diabetes.
Compared with first-line immunotherapy or chemotherapy alone, combination chemoimmunotherapy for advanced/metastatic non–small cell lung cancer has significantly higher antineoplastic drug and associated medical costs.
Medicare Part D low-income subsidies alone are insufficient to improve the uptake and equitable use of high-cost, orally administered antimyeloma therapy.
Ferring Pharmaceuticals today announced three oral presentations and one poster presentation at Digestive Disease Week DDW 2023 for REBYOTA fecal microbiota live jslm a firstinclass singledose microbiomebased treatment approved by the U.S. Food and Drug Administration FDA for the prevention of recurrent C. difficile C. diff infection in individuals 18 years of age and older following antibiotic treatment for recurrent C. diff infection.